CAS: 21561-09-1 - 4-Quinazolinamine, 6,7-dimethoxy-N-phenyl-
Formula:C16H15N3O2
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 4-Quinazolinamine, 6,7-dimethoxy-N-phenyl- REF: IN-DA007PY5CAS: 21561-09-1 | 98% | 25.00 €~177.00 € | Mon 02 Dec 24 |
 | WHI-P258 REF: TM-T2035CAS: 21561-09-1 | 99.59% - 99.95% | 34.00 €~893.00 € | Tue 10 Dec 24 |
 | 4-Phenylamino-6,7-dimethoxyquinazoline REF: 3D-WAA56109CAS: 21561-09-1 | Min. 95% | To inquire | Mon 13 Jan 25 |
4-Quinazolinamine, 6,7-dimethoxy-N-phenyl-
CAS:21561-09-1
Formula:
C16H15N3O2
Purity:
98%
Color and Shape:
Solid
Molecular weight:
281.3092
Ref: IN-DA007PY5
| 5mg | 53.00 € | ||
| 10mg | 66.00 € | ||
| 25mg | 105.00 € | ||
| 100mg | 153.00 € |
Estimated delivery in United States, on Monday 2 Dec 2024
WHI-P258
CAS:21561-09-1
WHI-P258, a weak JAK3 inhibitor, is used as a negative control in drug development.
Formula:
C16H15N3O2
Purity:
99.59% - 99.95%
Color and Shape:
Solid
Molecular weight:
281.31
- Inhibitors
- EGFR
- JNK
- Tyrosine Kinase/Adaptors
- See more categories
- PI3K/Akt/mTOR Signaling
Ref: TM-T2035
| 5mg | 34.00 € | ||
| 10mg | 51.00 € | ||
| 25mg | 88.00 € | ||
| 50mg | 140.00 € | ||
| 100mg | 230.00 € | ||
| 200mg | 336.00 € | ||
| 1mL*10mM (DMSO) | 39.00 € |
Estimated delivery in United States, on Tuesday 10 Dec 2024
4-Phenylamino-6,7-dimethoxyquinazoline
CAS:21561-09-1
4-Phenylamino-6,7-dimethoxyquinazoline is a synthetic compound that has been shown to have anticancer activity. It is …
Formula:
C16H15N3O2
Purity:
Min. 95%
Molecular weight:
281.31 g/mol
Ref: 3D-WAA56109
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire | ||
| 100mg | To inquire |
Estimated delivery in United States, on Monday 13 Jan 2025
